000 | 01346 a2200361 4500 | ||
---|---|---|---|
005 | 20250517201503.0 | ||
264 | 0 | _c20190304 | |
008 | 201903s 0 0 eng d | ||
022 | _a2152-2669 | ||
024 | 7 |
_a10.1016/j.clml.2018.01.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOllila, Thomas A | |
245 | 0 | 0 |
_aMarrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease. _h[electronic resource] |
260 |
_bClinical lymphoma, myeloma & leukemia _c03 2018 |
||
300 |
_a204-209 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBlood Cell Count _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInduction Chemotherapy _xmethods |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aOlszewski, Adam J | |
700 | 1 | _aButera, James N | |
700 | 1 | _aQuesenberry, Matthew I | |
700 | 1 | _aQuesenberry, Peter J | |
700 | 1 | _aReagan, John L | |
773 | 0 |
_tClinical lymphoma, myeloma & leukemia _gvol. 18 _gno. 3 _gp. 204-209 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clml.2018.01.007 _zAvailable from publisher's website |
999 |
_c28076636 _d28076636 |